Feasibility of salvage chemotherapy for refractory or relapsed non-Hodgkin's lymphoma with two topoisomerase II inhibitors, MST-16 and VP-16
スポンサーリンク
概要
著者
-
NAOE Tomoki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
KAGAMI Yoshitoyo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
KANAMARU Akihisa
Second Department of Internal Medicine, Hyogo College of Medicine
-
HORIUCHI Atsushi
Third Department of Internal Medicine, Kinki University School of Medicine
-
Kanamaru Akihisa
Second Department Of Internal Medicine Hyogo College Of Medicine
-
Naoe Tomoki
Department Of Hematologly And Oncology Nagoya University School Of Medicine
-
MASAOKA Tohru
Fifth Department of Internal Medicine, Osaka Medical Center for Cancer and Cardiovascular Diseases
-
Kagami Yoshitoyo
Department Of Hematology And Chemotherapy Aichi Cancer Center
-
Naoe Tomoki
Department Of Internal Medicine Tochigi Cancer Center
-
Masaoka Tohru
Fifth Department Of Internal Medicine Center For Abult Disease
-
Masaoka Tohru
Fifth Department Of Internal Medicine Osaka Adult Disease Center
-
ARIYOSHI Yutaka
Department of Hematology and Chemotherapy, Aichi Cancer Center
-
KANO Yasuhiko
Department of Internal Medicine, Tochigi Cancer Center
-
OGURO Masao
Department of Hematology and Chemotherapy, Chiba Cancer Center
-
OHNO Ryouzo
Third Department of Internal Medicine, Hamamatsu University School of Medicine
-
SAMPI Kazumi
Department of Hematology Clinic, Saitama Cancer Center
-
SHIRAKAWA Shigeru
Second Department of Internal Medicine, Mie University School of Medicine
-
FURUE Hisashi
Fourth Department of Internal Medicine, Teikyo University School of Medicine
-
Oguro Masao
Department Of Hematology And Chemotherapy Chiba Cancer Center
-
Ohno Ryouzo
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Sampi Kazumi
Department Of Hematology Clinic Saitama Cancer Center
-
Furue Hisashi
Fourth Department Of Internal Medicine Teikyo University School Of Medicine
-
Horiuchi Atsushi
Third Department Of Internal Medicine Kinki University School Of Medicine
-
Kagami Yoshitoyo
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Kano Yasuhiko
Department Of Internal Medicine Tochigi Cancer Center
-
Shirakawa Shigeru
Second Department Of Internal Medicine Mie University School Of Medicine
-
Ariyoshi Y
Aichi Prefectural Hospital Okazaki Jpn
-
Horiuchi Atsushi
Third Department Of Internai Medicine Kinki University Sohool Of Medicine
関連論文
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- Promoter Hypermethylation of the DNA-Repair Gene O^6-Methylguanine-DNA Methyltransferase and p53 Mutation in Diffuse Large B-Cell Lymphoma
- Loss of O^6-Methylguanine-DNA Methyltransferase Protein Expression Is a Favorable Prognostic Marker in Diffuse Large B-Cell Lymphoma
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- Donor cell leukemia after allogeneic peripheral blood stem cell transplantation : a case report and literature review
- Prediction of Sensitivity to STI571 among Chronic Myeloid Leukemia Patients by Genome-wide cDNA Microarray Analysis
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
- Definite diagnosis in Japanese patients with protein C deficiency by identification of causative PROC mutations
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapy
- Mutational analysis of SOS1 gene in acute myeloid leukemia
- Clinical significance of minimal residual disease in patients with t(8;21) acute myeloid leukemia in Japan
- Evaluation of organ involvement in intravascular large B-cell lymphoma by ^F-fluorodeoxyglucose positron emission tomography
- Identification of amino acid residues responsible for von Willebrand factor binding to sulfatide by charged-to-alanine-scanning mutagenesis
- Sustained Remission after Rituximab-containing Chemotherapy for Intravascular Large B-cell Lymphoma
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- Wilms' tumor 1 message and protein expression in bone marrow failure syndrome and acute leukemia
- Epigenetic Regulation of CD20 Protein Expression in a Novel B-Cell Lymphoma Cell Line, RRBL1, Established from a Patient Treated Repeatedly with Rituximab-Containing Chemotherapy
- BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia
- Successful Treatment with Imatinib Mesylate of a CML Patient in Megakaryoblastic Crisis with Severe Fibrosis
- Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
- No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study
- Safety and Efficacy of Autologous Progenitor Cell Transplantation for Therapeutic Angiogenesis in Patients With Critical Limb Ischemia
- Downregulation of microRNAs-143 and -145 in B-cell malignancies
- let-7 MicroRNA Functions as a Potential Growth Suppressor in Human Colon Cancer Cells(Molecular and Cell Biology)
- A Case of Interstitial Pneumonia Induced by Rituximab Therapy
- Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991
- Chemical Speciation of Arsenic Species in Human Blood Serum by Liquid Chromatography Using a Phosphatidylcholine-Coated ODS Column with Detection by ICP-MS
- Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
- Primary Hepatic Follicular Lymphoma : A Case Report and Discussion of Chemotherapy and Favorable Outcomes
- Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
- Senile Epstein-Barr Virus-Associated B-Cell Lymphoproliferative Disorders : a Mini Review
- Polymorphism of dihydropyrimidine dehydrogenase (DPYD) Cys29Arg and risk of six malignancies in Japanese
- CD56/NCAM-Positive Langerhans Cell Sarcoma : A Clinicopathologic Study of 4 Cases
- Phenotypic analysis of peripheral T/NK cell lymphoma : Study of 408 Japanese cases with special reference to their anatomical sites
- Pilot Phase I/II Study of New Salvage Therapy(CHASE) for Refractory or Relapsed Malignant Lymphoma
- Central nervous system involvement in intravascular large B-cell lymphoma : A retrospective analysis of 109 patients
- Establishment of a Stroma-Dependent Human Acute Myelomonocytic Leukemia Cell Line, NAMO-2, with FLT3 Tandem Duplication
- Recurrent Intramural Hematoma of the Small Intestine in a Severe Hemophilia A Patient with a High Titer of Factor VIII Inhibitor : A Case Report and Review of the Literature
- High Titer of ADAMTS13 Inhibitor Associated with Thrombotic Microangiopathy of the Gut and Skeletal Muscle after Allogeneic Hematopoietic Stem Cell Transplantation
- Apoptotic Cytotoxic Effects of a Histone Deacetylase Inhibitor, FK228, on Malignant Lymphoid Cells
- Peripheral T/Natural Killer - Cell Lymphoma Involving the Female Genital Tract: A Clinicopathologic Study of 5 Cases
- CD34^+-Selected Autologous Peripheral Blood Stem Cell Transplantation Conditioned With Total Body Irradiation for Malignant Lymphoma: Increased Risk of Infectious Complications
- Assessment of Prognostic Factors in Follicular Lymphoma Patients
- A high dose chemoradiotherapy and peripheral blood stem cell support combined with the CD34^+-selection method in cyclin D1^+-mantle cell lymphoma
- Somatic Hypermutations in the V_H Segment of Immunoglobulin Genes of CD5-positive Diffuse Large B-Cell Lymphomas
- NAD(P)H : quinone oxidoreductase 1 (NQ01) C609T polymorphism and the risk of eight cancers for Japanese
- Azole resistant Candida albicans in a leukemic patient : a case report
- Interaction of von Willebrand Factor with the Extracellular Matrix and Glycocalicin under Static Conditions^1
- Re-Treatment of Relapsed Indolent B-Cell Lymphoma With Rituximab
- Recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia
- Spontaneous regression of aleukemic leukemia cutis harboring a NPM/RARA fusion gene in an infant with cutaneous mastosytosis
- Correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients
- Detection of donor-type alveolar macrophages in transplantation with highly purified CD34^+ bone marrow cells
- Biology, Clinical Relevance, and Molecularly Targeted Therapy in Acute Leukemia with FLT3 Mutation
- Nucleophosmin : A versatile molecule associated with hematological malignancies
- Mechanism-based Therapy for Leukemia: A Lesson from Atra Therapy
- Karyotypically independent clones with del(11q) and trisomy 10 in acute myeloid leukemia : trisomy 10 may appear as an additional change
- Antitumor effect of arsenic trioxide in murine xenograft model
- Cytotoxic large T-cell lymphoma with fulminant clinical course,CD8^+ and CD56^-phenotype, and its relation to Epstein-Barr virus:a report of two cases
- Clinicopathologic study of nasal T/NK-cell lymphoma among the Japanese
- Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype
- Stable Engraftment after a Conditioning Regimen with Fludarabine and Melphalan for Bone Marrow Transplantation from an Unrelated Donor
- Quality of Life in Adult Patients after Bone Marrow Transplantation
- Irrespective of CD34 expression, lineage-committed cell fraction reconstitutes and re-establishes transformed Philadelphia chromosome-positive leukemia in NOD/SCID/IL-2Rγc^ mice
- Severe hemophilia A in a Japanese female caused by an F8-intron 22 inversion associated with skewed X chromosome inactivation
- Classic Polyarteritis Nodosa Presenting Rare Clinical Manifestations in a Patient with Hemophilia A
- Ectopic Expression of MAFB Gene in Human Myeloma Cells Carrying (14;20)(q32;q11) Chromosomal Translocations
- Acute myeloid leukemia in the elderly : 159 Nagoya case studies
- Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines
- Growth Inhibition of CD20-positive B Lymphoma Cell Lines by IDEC-C2B8 Anti-CD20 Monoclonal Antibody
- Clinical differences between hypoplastic and normocellular or hyperplastic myelodysplastic syndrome
- Comparative effects of three nitrosourea derivatives on cell cycle kinetics
- Prognostic significance of bone marrow lymphocyte counts in the nadir phase of acute myelocytic leukemia
- Toxic effects of arsenic (As^) and other metal ions on acute promelocytic leukemia cells
- Immunoglobulin Variable Region Structure and B-Cell Malignancies
- Development of novel humanized anti-CD20 antibodies based on affinity constant and epitope
- Feasibility of salvage chemotherapy for refractory or relapsed non-Hodgkin's lymphoma with two topoisomerase II inhibitors, MST-16 and VP-16
- Interferon-γ modulate Ia antigen expression on thymic reticuloepithelial cells in New Zealand mice
- Immunoaffinity Purification and Characterization of CACGTG Sequence-Binding Proteins from Cultured Mammalian Cells Using an Anti c-Myc Monoclonal Antibody Recognizing the DNA-Binding Domain
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Expanded distribution of the T315I mutation among hematopoietic stem cells and progenitors in a chronic myeloid leukemia patient during imatinib treatment
- Selective KIT inhibitor KI-328 and HSP90 inhibitor show different potency against the type of KIT mutations recurrently identified in acute myeloid leukemia
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
- Virus-Associated Hemophagocytic Syndrome Caused by Pandemic Swine-Origin Influenza A (H1N1) in a Patient After Unrelated Bone Marrow Transplantation
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- A novel insertion mutation of K294RGG within BCR-ABL kinase domain confers imatinib resistance : sequential analysis of the clonal evolution in a patient with chronic myeloid leukemia in blast crisis
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation : macrophage-targeted steroid therapy
- Mutation of ARHGAP9 in patients with coronary spastic angina
- Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia : the JALSG GML200 Study
- Efficacy and safety of human adipose tissue-derived mesenchymal stem cells for supporting hematopoiesis
- Guest editorial : Introducing progress in hematology in this issue